Tuen Mun Hospital

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Chronic kidney disease1 trial
• Fatty liver disease (MASLD/MASH)1 trial
• Gastric and oesophageal cancer1 trial
• Prostate cancer1 trial

Phase

• Phase 31 trial
• Phase 41 trial

Status

• Active, not recruiting1 trial
• Completed1 trial
• Enrolling by invitation1 trial
• Not yet recruiting1 trial

Lead sponsor

• Bayer1 trial
• Daiichi Sankyo Co., Ltd.1 trial
• Eli Lilly and Company1 trial
• Tuen Mun Hospital1 trial

Running trials

• Recruiting

  A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

  NCT07165028· Phase 3· Eli Lilly and Company· Source

  Contact: Tsz Fai Cheng (principal investigator)

• Enrolling by invitation

  Dialysis Efficiency and Transporter Evaluation Computational Tool in Peritoneal Dialysis

  NCT06842927· Tuen Mun Hospital· Source

• Active, not recruiting

  RADIANT: A Study of Radium-223 Dichloride (Xofigo) vs Enzalutamide or Abiraterone (ARPIs, Androgen Receptor Pathway Inhibitors) in Patients With Prostate Cancer That Has Spread to the Bones (mCRPC, Metastatic Castration-Resistant Prostate Cancer)

  NCT04597125· Phase 4· Bayer· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Chronic kidney disease1 recruiting
• Fatty liver disease (MASLD/MASH)1 recruiting

Closed trials

• Completed

  Real-World Observational Study to Describe Treatment Patterns in Patients With HER2-Positive Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer in East Asia

  NCT05606094· Daiichi Sankyo Co., Ltd.· Source